Kritika Agarwal speaks to The Hindu Business Line on indemnity for vaccine makers

Aug 24, 2021

Kritika Agarwal, Associate Partner – Corporate/M&A and Competition spoke to The Hindu Business Line on Indemnity for vaccine makers. According to her, “vaccine manufacturers may not want to spend time and money on defending any claims in all the countries where they supply and be subject to extensive litigation.”

Read the full article here.

More News

Majmudar & Partners IFLR1000 2022 Rankings

Majmudar & Partners has been recognized among the IFLR1000 2022 rankings across fields of practice and sectors. The firm has been ranked for its excellence in practice areas such as M&A, Banking, Private Equity, and Capital Markets among others ones. Akil...

read more